Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.

Bibliographic Information

Title
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
Author
Yoshinori Ito, Koichi Nagasaki, Yoshio Miki, Takuj Iwase, Futoshi Akiyama, Masaaki Matsuura, Rie Horii, Masujiro Makita, Nahomi Tokudome, Masaru Ushijima, Masataka Yoshimoto, Shunji Takahashi, Tetsuo Noda, Kiyohiko Hatake.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782115821325
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top